[HTML][HTML] Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
JS Tregoning, KE Flight, SL Higham, Z Wang… - Nature reviews …, 2021 - nature.com
Where 2020 saw the development and testing of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has …
syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has …
[HTML][HTML] Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic
Determining the transmissibility, prevalence and patterns of movement of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is central to our understanding …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is central to our understanding …
[HTML][HTML] Antibody evasion by the P. 1 strain of SARS-CoV-2
Terminating the SARS-CoV-2 pandemic relies upon pan-global vaccination. Current
vaccines elicit neutralizing antibody responses to the virus spike derived from early isolates …
vaccines elicit neutralizing antibody responses to the virus spike derived from early isolates …
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates
MG Joyce, HAD King, I Elakhal-Naouar… - Science translational …, 2021 - science.org
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
stresses the continued need for next-generation vaccines that confer broad protection …
stresses the continued need for next-generation vaccines that confer broad protection …
SARS-CoV-2 viral variants—tackling a moving target
In this issue of JAMA, Zhang and colleagues1 report the emergence of a novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) variant in Southern California that …
respiratory syndrome coronavirus 2 (SARS-CoV-2) variant in Southern California that …
[HTML][HTML] Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Understanding vaccine-elicited protection against SARS-CoV-2 variants and other
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
sarbecoviruses is key for guiding public health policies. We show that a clinical stage …
[HTML][HTML] SARS-CoV-2 variants of concern
Since the COVID-19 pandemic first began in December 2019, the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) virus has continuously evolved with many variants …
syndrome coronavirus 2 (SARS-CoV-2) virus has continuously evolved with many variants …
[HTML][HTML] Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
W Wang, S Lusvarghi, R Subramanian, NJ Epsi… - Cell host & …, 2022 - cell.com
The rapid emergence of SARS-CoV-2 variants challenges vaccination strategies. Here, we
collected 201 serum samples from persons with a single infection or multiple vaccine …
collected 201 serum samples from persons with a single infection or multiple vaccine …
[HTML][HTML] The role of B cells in COVID-19 infection and vaccination
S Chen, F Guan, F Candotti, K Benlagha… - Frontiers in …, 2022 - frontiersin.org
B cells secrete antibodies and mediate the humoral immune response, making them
extremely important in protective immunity against SARS-CoV-2, which caused the …
extremely important in protective immunity against SARS-CoV-2, which caused the …
[HTML][HTML] Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants
Despite an unprecedented global gain in knowledge since the emergence of SARS-CoV-2,
almost all mechanistic knowledge related to the molecular and cellular details of viral …
almost all mechanistic knowledge related to the molecular and cellular details of viral …